IDE Monoclonal Antibody
-
中文名稱：IDE鼠單克隆抗體
-
貨號：CSB-MA000241
-
規(guī)格：￥1090
-
圖片：
-
Western blot analysis of 1) Hela, 2) HepG2, diluted at 1:2000
-
-
其他：
產(chǎn)品詳情
-
產(chǎn)品描述：IDE單克隆抗體（CUSABIO貨號：CSB-MA000241）是針對胰島素降解酶（Insulin-Degrading Enzyme, IDE）研發(fā)的高特異性科研試劑，該靶點在維持血糖穩(wěn)態(tài)及神經(jīng)退行性疾病研究中具有關(guān)鍵作用。IDE不僅參與胰島素代謝調(diào)控，還能降解阿爾茨海默病相關(guān)的β淀粉樣蛋白，是代謝性疾病與神經(jīng)退行機制交叉研究的重點分子。本產(chǎn)品經(jīng)ELISA和Western Blot（WB）嚴格驗證，可精準識別人源IDE蛋白，適用于體外實驗中對目標蛋白的定性與半定量分析。其高親和力特性支持復(fù)雜樣本體系中的低豐度靶點檢測，為糖尿病發(fā)病機制、淀粉樣蛋白代謝通路及藥物靶點篩選等研究提供可靠工具。在應(yīng)用場景上，該抗體可廣泛用于細胞裂解液、組織提取液等樣本的蛋白互作分析、信號通路探索及疾病模型構(gòu)建，助力胰島素抵抗、認知功能障礙等領(lǐng)域的分子機制解析。作為專為科研設(shè)計的IDE單克隆抗體，本產(chǎn)品為代謝組學(xué)、神經(jīng)科學(xué)及生物標志物發(fā)現(xiàn)提供優(yōu)質(zhì)解決方案。
-
Uniprot No.：
-
基因名：
-
別名：Abeta-degrading protease antibody; FLJ35968 antibody; Ide antibody; IDE_HUMAN antibody; Insulin protease antibody; Insulin-degrading enzyme antibody; Insulinase antibody; Insulysin antibody; OTTHUMP00000020097 antibody
-
宿主：Mouse
-
反應(yīng)種屬：Human
-
免疫原：Synthetic Peptide
-
免疫原種屬：H
-
標記方式：Non-conjugated
-
抗體亞型：IgG
-
克隆號：17B4
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：PBS, pH 7.4, containing 0.5%BSA, 0.02% sodium azide as Preservative and 50% Glycerol.
-
產(chǎn)品提供形式：Liquid
-
應(yīng)用范圍：ELISA,WB
-
推薦稀釋比：
Application Recommended Dilution WB 1:500-1:5000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情
-
功能：Plays a role in the cellular breakdown of insulin, APP peptides, IAPP peptides, natriuretic peptides, glucagon, bradykinin, kallidin, and other peptides, and thereby plays a role in intercellular peptide signaling. Substrate binding induces important conformation changes, making it possible to bind and degrade larger substrates, such as insulin. Contributes to the regulation of peptide hormone signaling cascades and regulation of blood glucose homeostasis via its role in the degradation of insulin, glucagon and IAPP. Plays a role in the degradation and clearance of APP-derived amyloidogenic peptides that are secreted by neurons and microglia (Probable). Degrades the natriuretic peptides ANP, BNP and CNP, inactivating their ability to raise intracellular cGMP. Also degrades an aberrant frameshifted 40-residue form of NPPA (fsNPPA) which is associated with familial atrial fibrillation in heterozygous patients. Involved in antigen processing. Produces both the N terminus and the C terminus of MAGEA3-derived antigenic peptide (EVDPIGHLY) that is presented to cytotoxic T lymphocytes by MHC class I.; (Microbial infection) The membrane-associated isoform acts as an entry receptor for varicella-zoster virus (VZV).
-
基因功能參考文獻：
- These results support the hypothesis that IDE gene expression in different areas of Alzheimer's patient's brains. PMID: 28164769
- People with allelic variation in four genes related to cardiovascular diseases and metabolism were more likely to die: apolipoprotein (APO)C1 GG and AG carriers, APOE varepsilon4 carriers, insulin-degrading enzyme (IDE) TC carriers, and phosphatidylinositol 3-kinase (PI3KCB) GG carriers. PMID: 27806189
- Data suggest the possibility of development of insulin-degrading enzyme (IDE)-based drugs for the treatment of the late-onset form of Alzheimer's disease (AD). PMID: 27982586
- the mechanistic and molecular features of IDE-26S proteasome interaction in a cell experimental model, is reported. PMID: 26186340
- No significant associations have been found between other IDE gene single nucleotide polymorphisms of rs4646953, rs2251101 and rs1544210 with Alzheimer disease. PMID: 25105907
- results demonstrate that the polymorphisms rs1887922 and rs1999764 of the IDE gene are associated with late-onset Alzheimer disease susceptibility in the Xinjiang Han population PMID: 25414272
- Cognitive impairment is more frequent among those exposed to the C allele of the rs2209972 SNP of the insulin degrading enzyme gene. PMID: 24355596
- IDE does not play a major role in MHC class I antigen processing, confirming the dominant and almost exclusive role of the proteasome in cytosolic production of MHC class I ligands. PMID: 24516642
- using combinational in silico investigations, study identified that pathogenic nonsynonymous mutations corresponding to p.I54F, p.P122T, p.T533R, p.P581A and p.Y609A have more potential role in structural and functional deviations of IDE activity PMID: 24059301
- Our study provided evidence to IDE, PON1, WFS1, POU2F1, IL1alpha and IL1beta associated with T2D in Pakistanis. PMID: 24477584
- An upstream promoter element which blocks the antisense transcription of the human IDE promoter, was identified. PMID: 23797320
- Both IDE and type 2 diabetes are associated with executive function levels in older adults PMID: 23597493
- Conformational changes in IDE, including a swinging-door mechanism that permits the entry of short peptides into the catalytic chamber, governs the selective destruction of amyloidogenic peptides. PMID: 23922390
- for the rs1832196 polymorphism, significant association with Alzheimer disease was found by the dominant model in overall and subgroup analysis. PMID: 23416320
- IDE-Met(1) links the mitochondrial biogenesis pathway with mitAbeta levels and organelle functionality. PMID: 23525105
- Genetic variants for both insulin degrading enzyme (IDE) and angiotensin converting enzyme (ACE) in relation to cognitive phenotype. PMID: 21232820
- In the context of APOEepsilon4-negative status, insulin-degrading enzyme variants are significantly associated with Alzheimer disease in some genetic models. PMID: 22502914
- The polymorphism of insulin-degrading enzyme is associated with susceptibility to Alzheimer's disease in Han Chinese. PMID: 20880607
- Phosphorylation of amyloid-beta peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes. PMID: 22267728
- The upstream polymorphism IDE2 was found to influence AD risk and to trigger the Abeta42 plasma level, whereas the downstream polymorphism IDE7 modified the T2DM risk; no associations were found for the intronic variant IDE9. PMID: 22107728
- Significant differences were found in the response to induced ketosis among non-carriers of putative gain-of-function polymorphisms in rs1143627 and rs16944 in the IL-1beta gene and among variants of the polymorphism rs2251101 in the insulysin gene. PMID: 21992747
- BRI2 protein regulates beta-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE). PMID: 21873424
- Five IDE variants for altered in vitro reporter gene expression, based on their presence on haplotypes (H2, H6 and H9) and their association with altered IDE mRNA transcript levels , were tested. PMID: 21731745
- dimers of insulin-degrading enzyme reveal a cis activation mechanism PMID: 21343292
- IDE cleaves ubiquitin in a biphasic manner PMID: 21185309
- the evolutionarily conserved IDE may play a key role in modulating and reshaping the strength and duration of NP-mediated signaling. PMID: 21098034
- IIA(Glc) of the sugar phosphotransferase system regulates the peptidase activity of a mammalian insulysin homolog in V. vulnificus. PMID: 20971110
- Insulin degrading enzyme is linked with aggregated Abeta40 isoform while neprilysin negatively correlates with amyloid angiopathy. PMID: 19019493
- IDE is not correlated with amyloig beta or clinical diagnosis Alzheimer disease PMID: 20663017
- produce tumor antigenic peptides presented by MHC class I molecules for cytotoxic T lymphocyte recognition PMID: 20364150
- the catalytic mechanisms for the hydrolysis of the three different peptide bonds of Alzheimer amyloid beta (Abeta) peptide by insulin-degrading enzyme (IDE) PMID: 20033747
- this study more generally suggests an interplay between RB and IDE within the proteasome that may have important growth-regulatory consequences. PMID: 20362553
- Results describe the in vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme. PMID: 20082125
- In comparison to Abeta40, Abeta42 is more flexible and interacts through a smaller number (17-22) of hydrogen bonds in the catalytic chamber of IDE. PMID: 20380468
- a previously unreported variant unequivocally associated with increased IDE expression was also associated with reduced plasma Abeta40 and decreased LOAD susceptibility PMID: 20098734
- Study verified associations of two IDE polymorphisms (rs1887922 and rs2149632) with type 2 diabetes risk in two independent German cohorts and evaluated in detail the association of common variants with insulin metabolism and glycemic traits. PMID: 19809796
- structural basis of how the high dipole moment of substrates complements the charge distribution of the IDE catalytic chamber for the substrate selectivity PMID: 19896952
- IDE protease binds to the 73-kDa gE precursor and that this event occurs in the cytosol but not as a receptor/ligand interaction. PMID: 19864391
- possible mechanism by which the insulin-degrading enzyme (IDE) zinc-binding protease carries out its catalytic function toward two peptides of different length PMID: 19785409
- Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). PMID: 11809755
- analysis of over 2,400 samples provides no compelling evidence that variation in IDE contributes to diabetes susceptibility in humans PMID: 12716770
- when intracellular long-chain fatty acid concentrations are elevated, they may act directly on insulin-degrading enzyme to decrease insulin metabolism and alter insulin action in intact cells and this mechanism may contribute to insulin resistance PMID: 12746301
- Polymorphism in this enzyme are associated with NIDDM in men. PMID: 12765971
- IDE gene polymorphisms do not confer susceptibility to early- or late-onset AD at least in a Japanese population. PMID: 14755451
- Biochemical characteristics of insulin degradation in wound fluid were consistent with characteristics of insulin-degrading enzyme. Reduction in insulin-degrading activity in wound fluid is potential therapeutic target. PMID: 14764804
- genomic region in the proximity of IDE that may contribute to Alzheimer and Parkinson disease in a similar manner. PMID: 15088150
- IDE gene promoter region variants are associated with AD in subjects without an epsilon4 allele PMID: 15181249
- Polymorphism in/near IDE contributes to a large proportion of variance in plasma insulin levels and correlated traits. PMID: 15277398
- The C allele of single-nucleotide polymorphism IDE2 associated with Alzheimer disease. There may be a possible synergic interaction between IDE & APOE epsilon4. PMID: 15277615
- a defect in Abeta proteolysis by IDE contributes to the accumulation of this peptide in the cortical microvasculature PMID: 15489232
顯示更多
收起更多
-
亞細胞定位：Cytoplasm, cytosol. Cell membrane. Secreted. Note=Present at the cell surface of neuron cells. The membrane-associated isoform is approximately 5 kDa larger than the known cytosolic isoform.
-
蛋白家族：Peptidase M16 family
-
組織特異性：Detected in brain and in cerebrospinal fluid (at protein level).
-
數(shù)據(jù)庫鏈接：
